Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Intravitreal triamcinolone acetonide for refractory diabetic macular oedema.

    Fernando AI, Pandit JC.

    J R Soc Med. 2005 Sep;98(9):421-2. No abstract available. PMID: 16140858 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes]

    Selim Kocabora M, Kucuksahin H, Gulkilik G, Taskapili M, Yilmazli C, Engin G.

    J Fr Ophtalmol. 2007 Jan;30(1):32-8. French. PMID: 17287669 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).

    Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.

    Br J Ophthalmol. 2008 Jan;92(1):76-80. Epub 2007 Oct 26.PMID: 17965109 [PubMed - indexed for MEDLINE]Related articles

    4.

    Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema.

    Jonas JB, Kreissig I, Degenring RF, Kamppeter BA.

    Br J Ophthalmol. 2005 Jan;89(1):122. No abstract available. PMID: 15615762 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.

    Ockrim ZK, Sivaprasad S, Falk S, Roghani S, Bunce C, Gregor Z, Hykin P.

    Br J Ophthalmol. 2008 Jun;92(6):795-9. Epub 2008 Apr 17.PMID: 18420749 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal triamcinolone acetonide for diabetic macular edema.

    Chieh JJ, Roth DB, Liu M, Belmont J, Nelson M, Regillo C, Martidis A.

    Retina. 2005 Oct-Nov;25(7):828-34.PMID: 16205559 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal triamcinolone for diffuse diabetic macular oedema.

    Longo A.

    Br J Ophthalmol. 2006 Sep;90(9):1079-80. No abstract available. PMID: 16929055 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes.

    Barak A, Regenbogen M, Goldstein M, Loewenstein A.

    Isr Med Assoc J. 2006 Feb;8(2):83-7.PMID: 16544727 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Intravitreal triamcinolone acetonide for the treatment of diffuse diabetic macular oedema--a case report.

    Wang C, Katz BJ, Turner MJ, Hu J, Zhang K.

    Ann Acad Med Singapore. 2006 Feb;35(2):112-4.PMID: 16565766 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms.

    Averbukh E, Banin E.

    Isr Med Assoc J. 2006 Feb;8(2):127-8. No abstract available. PMID: 16544738 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.

    Batioğlu F, Ozmert E, Parmak N, Celik S.

    Int Ophthalmol. 2007 Oct;27(5):299-306. Epub 2007 Apr 24.PMID: 17453151 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema.

    Avci R, Kaderli B, Akalp FD.

    Clin Experiment Ophthalmol. 2006 Jan-Feb;34(1):27-32.PMID: 16451255 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal triamcinolone for the treatment of diabetic macular edema.

    Gómez-Ulla F, Marticorena J, Alfaro DV 3rd, Fernández M, Méndez ER, Rothen M.

    Curr Diabetes Rev. 2006 Feb;2(1):99-112. Review.PMID: 18220620 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

    Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M.

    Ophthalmology. 2006 Sep;113(9):1533-8. Epub 2006 Jul 7.PMID: 16828501 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal triamcinolone in diabetic macular edema.

    Aslam S, Malik N, Davies N.

    Arch Ophthalmol. 2006 Oct;124(10):1506-7; author reply 1507. No abstract available. PMID: 17030730 [PubMed - indexed for MEDLINE]Related articles

    16.

    Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.

    Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoğlu B.

    J Diabetes Complications. 2006 Jul-Aug;20(4):246-51.PMID: 16798476 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.

    Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E.

    Br J Ophthalmol. 2002 Feb;86(2):247-8. No abstract available. PMID: 11815359 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.

    Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudric A, Massin P.

    Acta Ophthalmol Scand. 2006 Oct;84(5):624-30.PMID: 16965492 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal cortisone injection for refractory diffuse diabetic macular edema.

    Er H, Yilmaz H.

    Ophthalmologica. 2005 Nov-Dec;219(6):394-400.PMID: 16286802 [PubMed - indexed for MEDLINE]Related articles

    20.

    Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.

    Salti H, Farah T.

    Am J Ophthalmol. 2005 Nov;140(5):958; author reply 958-9. No abstract available. PMID: 16310498 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data